Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Healthequity (HQY) Acquisitions (2017 - 2022)

Healthequity has reported Acquisitions over the past 4 years, most recently at $455.0 million for Q1 2022.

For Q1 2022, Acquisitions changed N/A year-over-year to $455.0 million; the TTM value through Oct 2022 reached $455.0 million, up 818.58%, while the annual FY2022 figure was $504.5 million, N/A changed from the prior year.
Acquisitions for Q1 2022 was $455.0 million at Healthequity, up from $49.5 million in the prior quarter.
Over five years, Acquisitions peaked at $455.0 million in Q1 2022 and troughed at $14.5 million in Q1 2020.
A 3-year average of $173.0 million and a median of $49.5 million in 2021 define the central range for Acquisitions.